155 related articles for article (PubMed ID: 22985189)
1. Cosuspensions of microcrystals and engineered microparticles for uniform and efficient delivery of respiratory therapeutics from pressurized metered dose inhalers.
Vehring R; Lechuga-Ballesteros D; Joshi V; Noga B; Dwivedi SK
Langmuir; 2012 Oct; 28(42):15015-23. PubMed ID: 22985189
[TBL] [Abstract][Full Text] [Related]
2. Gamma scintigraphic pulmonary deposition study of glycopyrronium/formoterol metered dose inhaler formulated using co-suspension delivery technology.
Taylor G; Warren S; Dwivedi S; Sommerville M; Mello L; Orevillo C; Maes A; Martin UJ; Usmani OS
Eur J Pharm Sci; 2018 Jan; 111():450-457. PubMed ID: 29055732
[TBL] [Abstract][Full Text] [Related]
3. Drug Delivery from an Innovative LAMA/LABA Co-suspension Delivery Technology Fixed-Dose Combination MDI: Evidence of Consistency, Robustness, and Reliability.
Doty A; Schroeder J; Vang K; Sommerville M; Taylor M; Flynn B; Lechuga-Ballesteros D; Mack P
AAPS PharmSciTech; 2018 Feb; 19(2):837-844. PubMed ID: 29019170
[TBL] [Abstract][Full Text] [Related]
4. Templated open flocs of anisotropic particles for pulmonary delivery with pressurized metered dose inhalers.
Tam JM; Engstrom JD; Ferrer D; Williams RO; Johnston KP
J Pharm Sci; 2010 Jul; 99(7):3150-65. PubMed ID: 20187139
[TBL] [Abstract][Full Text] [Related]
5. Influence of propellant composition on drug delivery from a pressurized metered-dose inhaler.
Williams RO; Repka M; Liu J
Drug Dev Ind Pharm; 1998 Aug; 24(8):763-70. PubMed ID: 9876524
[TBL] [Abstract][Full Text] [Related]
6. The influence of initial atomized droplet size on residual particle size from pressurized metered dose inhalers.
Sheth P; Stein SW; Myrdal PB
Int J Pharm; 2013 Oct; 455(1-2):57-65. PubMed ID: 23911912
[TBL] [Abstract][Full Text] [Related]
7. Differences in physical chemistry and dissolution rate of solid particle aerosols from solution pressurised inhalers.
Buttini F; Miozzi M; Balducci AG; Royall PG; Brambilla G; Colombo P; Bettini R; Forbes B
Int J Pharm; 2014 Apr; 465(1-2):42-51. PubMed ID: 24491530
[TBL] [Abstract][Full Text] [Related]
8. Consequences of not-shaking and shake-fire delays on the emitted dose of some commercial solution and suspension pressurized metered dose inhalers.
Chierici V; Cavalieri L; Piraino A; Paleari D; Quarta E; Sonvico F; Melani AS; Buttini F
Expert Opin Drug Deliv; 2020 Jul; 17(7):1025-1039. PubMed ID: 32551990
[TBL] [Abstract][Full Text] [Related]
9. Humidity affects the morphology of particles emitted from beclomethasone dipropionate pressurized metered dose inhalers.
Ivey JW; Bhambri P; Church TK; Lewis DA; McDermott MT; Elbayomy S; Finlay WH; Vehring R
Int J Pharm; 2017 Mar; 520(1-2):207-215. PubMed ID: 28167262
[TBL] [Abstract][Full Text] [Related]
10. Sildenafil citrate monohydrate-cyclodextrin nanosuspension complexes for use in metered-dose inhalers.
Sawatdee S; Phetmung H; Srichana T
Int J Pharm; 2013 Oct; 455(1-2):248-58. PubMed ID: 23876498
[TBL] [Abstract][Full Text] [Related]
11. Isothermal microcalorimetry of pressurized systems I: a rapid method to evaluate pressurized metered dose inhaler formulations.
D'Sa DJ; Lechuga-Ballesteros D; Chan HK
Pharm Res; 2014 Oct; 31(10):2716-23. PubMed ID: 24760449
[TBL] [Abstract][Full Text] [Related]
12. A Review of Methods for Evaluating Particle Stability in Suspension Based Pressurized Metered Dose Inhalers.
D'Sa D; Chan HK
Curr Pharm Des; 2015; 21(27):3955-65. PubMed ID: 26290200
[TBL] [Abstract][Full Text] [Related]
13. Co-deposition of a triple therapy drug formulation for the treatment of chronic obstructive pulmonary disease using solution-based pressurised metered dose inhalers.
Adi H; Young PM; Traini D
J Pharm Pharmacol; 2012 Sep; 64(9):1245-53. PubMed ID: 22881437
[TBL] [Abstract][Full Text] [Related]
14. Is "Slow Inhalation" Always Suitable for Pressurized Metered Dose Inhaler?
Hira D; Okuda T; Mizutani A; Tomida N; Mizuno M; Ueshima S; Kakumoto M; Okano T; Okamoto H
AAPS PharmSciTech; 2020 Jan; 21(2):53. PubMed ID: 31907655
[TBL] [Abstract][Full Text] [Related]
15. Particle synergy and aerosol performance in non-aqueous liquid of two combinations metered dose inhalation formulations: an AFM and Raman investigation.
Rogueda PG; Price R; Smith T; Young PM; Traini D
J Colloid Interface Sci; 2011 Sep; 361(2):649-55. PubMed ID: 21714970
[TBL] [Abstract][Full Text] [Related]
16. Swellable hydrogel particles for controlled release pulmonary administration using propellant-driven metered dose inhalers.
Selvam P; El-Sherbiny IM; Smyth HD
J Aerosol Med Pulm Drug Deliv; 2011 Feb; 24(1):25-34. PubMed ID: 20961166
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, double-dummy, single-dose, efficacy crossover trial comparing formoterol-HFA (pMDI) versus formoterol-DPI (Aerolizer) and placebo (pMDI or Aerolizer) in asthmatic patients.
Bousquet J; Huchon G; Leclerc V; Vicaut E; Lefrançois G
Respiration; 2005; 72 Suppl 1():6-12. PubMed ID: 15915007
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro performance of valved holding chambers with a budesonide/formoterol pressurized metered-dose inhaler.
Chambers FE; Brown S; Ludzik AJ
Allergy Asthma Proc; 2009; 30(4):424-32. PubMed ID: 19772764
[TBL] [Abstract][Full Text] [Related]
19. Co-suspension delivery technology in pressurized metered-dose inhalers for multi-drug dosing in the treatment of respiratory diseases.
Ferguson GT; Hickey AJ; Dwivedi S
Respir Med; 2018 Jan; 134():16-23. PubMed ID: 29413503
[TBL] [Abstract][Full Text] [Related]
20. Performance of pressurized metered-dose inhalers at extreme temperature conditions.
Morin CMD; Ivey JW; Titosky JTF; Suderman JD; Olfert JS; Vehring R; Finlay WH
J Pharm Sci; 2014 Nov; 103(11):3553-3559. PubMed ID: 25252183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
